Design Sprint and Usability Testing of a Patient-Facing Diabetes Dashboard Embedded in an Existing Patient Portal Mobile App

项目摘要/摘要 糖尿病是肾衰竭、心脏病、中风、视力障碍和非创伤性疾病的主要原因 截肢手术。糖尿病自我护理和预防性健康服务可以预防或延迟许多 糖尿病相关并发症，但很少有患者始终如一地得到所有推荐的服务或从事 推荐的自我照顾行为，这些行为很难实施和维持。 数据越来越支持面向患者的移动健康应用程序在改变健康行为方面的作用， 加强自我护理，方便糖尿病患者获得医疗服务。然而，差异 在糖尿病移动健康应用的设计和可用性方面，导致了不同程度的患者参与度和 对血糖控制的影响不一致。许多糖尿病移动健康应用程序由于以下一种或多种原因而缺乏疗效 以下问题：(A)缺乏以用户为中心的设计；(B)缺乏与医疗保健提供系统的整合； (C)缺乏最大限度地提高患者参与度的关键特征，包括以患者为中心的激励策略； 和/或(D)未能考虑到老年患者和健康素养有限的人的独特需求。 研究支持以用户为中心的设计方法、可用性测试以及与个人的同步 健康记录和患者Web门户，以最大限度地发挥移动健康应用程序的有效性，并克服 存在的挑战。此外，最近发布的一个框架确定了促进患者健康的关键战略 使用移动健康应用，范围从提供教育信息到支持行为 利用游戏设计和竞争的元素来改变奖励。 通过应用以用户为中心的设计方法、患者参与度的关键策略和可用性 评估，我们的目标是：(1)设计一个嵌入现有患者的面向患者的糖尿病仪表板 一款满足不同患者群体(包括老年人和有 有限的健康素养)使用2型糖尿病，以及(2)评估面向患者的可用性 糖尿病移动仪表盘是在AIM 1中开发的。 这些目标与父K23应用程序的目标一致，即设计和测试与 糖尿病仪表板嵌入到免费的患者网络门户桌面应用程序中。自……开始以来 家长K23奖，开发了一个患者门户移动应用程序，现在可以在iOS和 Android移动操作系统，提供了将桌面应用程序转换为移动应用程序的机会 站台。移动平台通过增加可移植性为桌面应用程序提供了重要的补充， 便利性和功能性，并随之而来的与屏幕大小、手势相关的新设计机会 (例如，滑动)、通知和导航。最后，根据R03奖的目标， 拟议的研究将进一步扩展PI和Products的设计和可用性评估经验 在随后的R01应用中提出的随机对照试验的计划所必需的数据。

Project Summary/Abstract Diabetes is a leading cause of kidney failure, heart disease, stroke, visual impairment, and non-traumatic lower limb amputations. Diabetes self-care and preventative health services can prevent or delay many diabetes-related complications, yet few patients consistently receive all recommended services or engage in recommended self-care behaviors that are challenging to implement and sustain. Data increasingly support the role of patient-facing mobile health apps to modify health behavior, enhance self-care, and facilitate access to healthcare services for patients with diabetes. However, differences in the design and usability of diabetes mobile health apps have led to varying levels of patient engagement and inconsistent effects on glycemic control. Many diabetes mobile health apps lack efficacy due to one or more of the following: (a) absence of user-centered design, (b) lack of integration with the healthcare delivery system, (c) absence of key features to maximize patient engagement including patient-centered motivational strategies, and/or (d) failure to account for the unique needs of older patients and those with limited health literacy. Research supports user-centered design methods, usability testing, and synchronization with personal health records and patient web portals to maximize the effectiveness of mobile health apps and overcome existing challenges. In addition, a recently published framework identifies key strategies to promote patient engagement with mobile health apps that range from providing educational information to supporting behavior change with rewards using elements of game design and competition. By applying user-centered design methodology, key strategies for patient engagement, and usability assessments, we aim to: (1) design a patient-facing diabetes dashboard embedded within an existing patient web portal mobile app that is satisfying for a diverse group of patients (including older adults and those with limited health literacy) with type 2 diabetes to use, and (2) assess the usability over time of the patient-facing diabetes mobile dashboard developed in Aim 1. These objectives are in concert with the parent K23 application's goal of designing and testing a related diabetes dashboard embedded in a complimentary patient web portal desktop application. Since the start of the parent K23 award, a patient web portal mobile app was developed and is now available on iOS and Android mobile operating systems, providing an opportunity to translate the desktop application to the mobile platform. Mobile platforms offer an important compliment to desktop applications by increasing portability, convenience, and functionality, and bring with it new design opportunities related to screen size, hand gestures (e.g., swiping), notifications, and navigation. Finally, in accordance with the goals of the R03 award, the proposed research will further extend the design and usability assessment experience of the PI and produce data essential to the planning of a randomized controlled trial to be proposed in subsequent R01 application.